Cognitive & brain health
The cognitive-enhancement corner spans Russian research peptides, longevity nootropics, and sleep interventions. The Semax evidence review looks at what researchers measured and how directly those studies speak to the claims made about cognition. A few have meaningful human data; most are preclinical or rest on small, hard-to-replicate studies. Here is the honest evidence, grouped by how it's used.
Nootropic peptides
The peptides marketed for focus, memory, and neuroprotection.
Semax: a real Russian nootropic with an under-tested evidence base
An ACTH(4-10)-derived heptapeptide that raises BDNF and is a registered drug in Russia. The mechanism is credible — but the human evidence is small, single-country, and mostly uncontrolled.
Selank: a non-benzodiazepine anxiolytic peptide, lightly tested
A tuftsin-analog heptapeptide that modulates GABA without being a benzodiazepine — and matched benzodiazepines in small Russian trials. The mechanism is credible; the evidence base is thin.
Dihexa: a striking preclinical nootropic with zero human evidence
An orally-active angiotensin-IV–derived compound famous for building synapses “more potently than BDNF” in the lab. The animal data are real — but there are no human trials, and its c-Met growth-pathway mechanism raises unanswered safety questions.
P21 (P021): a neurogenic peptide with real animal data and no human evidence
Marketed as “P21,” the compound is really P021 — a CNTF-derived peptide that boosts neurogenesis in rodents. There are no human trials, no approval, and a genuinely muddled name. A straight read of where the science stands.
Cerebrolysin: what it is, and what the evidence actually shows
A porcine-brain-derived peptide mixture sold abroad for stroke and dementia — and pitched online as a nootropic. A straight read of the Cochrane reviews and the regulatory reality.
Longevity nootropics & compounds
The non-peptide brain-support compounds in the longevity toolkit.
Alpha-GPC: What the Evidence Actually Shows
A cholinergic precursor with real dementia-trial data, weak ergogenic studies, and an unresolved 2021 stroke-risk signal.
Methylene blue: the longevity 'biohack' that's actually a drug
Low-dose methylene blue has a plausible mitochondrial mechanism and a real single-dose memory signal — but it's an FDA-approved drug, not a supplement, its anti-aging claims are preclinical, and it can cause fatal serotonin syndrome with antidepressants.
Phosphatidylserine: Evidence for Memory, Cortisol, and Cognitive Health
A membrane phospholipid with real biology, older positive cognition data on a form you can no longer buy, and a weaker case for the soy-derived version sold today.
Gotu Kola (Centella asiatica): What the Evidence Actually Shows
Strong for venous insufficiency and topical wound healing; the cognition and longevity claims rest on thin, mixed data.
Lithium orotate: an intriguing population signal, almost no direct evidence
Trace lithium in drinking water tracks with lower suicide and dementia rates — but that's an association, and lithium orotate itself has essentially no controlled human trials.
Sleep, mood & the cognition link
Because sleep and anxiety drive cognition as much as any nootropic does.
How to Increase Deep Sleep: What the Evidence Actually Shows
Deep (slow-wave) sleep is front-loaded into the early night and drives your biggest growth-hormone pulse — here are the levers that actually raise it, and an honest look at where peptides fall short.
Peptides for sleep: what actually has human evidence (and what doesn't)
DSIP, the GH-axis peptides and Selank all get marketed for sleep. Graded against controlled human data, none is an evidence-based sleep therapy — and the proven levers aren't injectable.
Peptides for anxiety: Selank, Semax and DSIP graded by real human evidence
Three peptides dominate the “peptides for anxiety” lists. Only one has meaningful human anxiety data — and none is approved or backed by large Western trials. A straight read.